The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Boyko A.N.

N.I. Pirogov Russian National Research Medical University;
Federal Center for Cerebrovascular Pathology and Stroke;
Neuro-Clinic LLC (Yusupov Hospital)

Bakhtiyarova K.Z.

Republican Clinical Hospital named after G.G. Kuvatov», Ufa, Russia

Dudin V.A.

Kirov Regional State Clinical Budgetary Healthcare Institution 'Cardiology and Neurology Centre', Kirov, Russia

Zaslavsky L.G.

State Budgetary Healthcare Institution 'Leningrad Regional Clinical Hospital', Saint Petersburg, Russia

Malkova N.A.

State Novosibirsk Regional Clinical Hospital

Parshina E.V.

Semashko Nizhny Novgorod Regional Clinical Hospital

Fedulov A.S.

State Institution 'Minsk Research and Development Centre of Surgery, Transplantology, and Haematology', Minsk, Republic Belarus

Zinkina-Orikhan A.V.

JSC «BIOCAD», St. Petersburg, Russia

Lin’kova Yu.N.

JSC «BIOCAD», St. Petersburg, Russia

Ivanov R.A.

JSC BIOCAD, Saint Petersburg, Russia

Chernovskaya T.V.

JSC 'BIOCAD', Saint Petersburg, Russia

The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis

Authors:

Boyko A.N., Bakhtiyarova K.Z., Dudin V.A., Zaslavsky L.G., Malkova N.A., Parshina E.V., Fedulov A.S., Zinkina-Orikhan A.V., Lin’kova Yu.N., Ivanov R.A., Chernovskaya T.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10‑2): 100‑109

Views: 7981

Downloaded: 320


To cite this article:

Boyko AN, Bakhtiyarova KZ, Dudin VA, et al. . The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10‑2):100‑109. (In Russ.)
https://doi.org/10.17116/jnevro2019119102100

Recommended articles:
Cognitive impairment in cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16
Respiratory-syncitial virus: biology, gene­tic dive­rsity and perspective control preparations. Mole­cular Gene­tics, Microbiology and Viro­logy. 2024;(1):16-24
A case of COVID-associated ence­phalopathy in a patient with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.